Want to see QTEX full AI Analyst Report?
QTEX Stock Chart & Stats
$0.86
-$0.05(-4.95%)
At close: 4:00 PM EST
$0.86
-$0.05(-4.95%)
Day’s Range― - ―
52-Week Range$0.28 - $3.85
Previous CloseN/A
VolumeN/A
Average Volume (3M)12.71M
Market Cap
$113.36M
Enterprise Value$56.30M
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$640.00K
Price to Earnings (P/E)―
Beta3.74
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding67,075,040
10 Day Avg. Volume35,536,550
30 Day Avg. Volume12,707,936
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)11.48
Price to Sales (P/S)92.25
P/FCF Ratio-2.68
Enterprise Value/Market Cap0.50
Enterprise Value/Revenue194.82
Enterprise Value/Gross Profit28.15K
Enterprise Value/Ebitda-7.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)$48.00M
Bulls Say, Bears Say
Bulls Say
Cryogenic Interconnect ValidationIndependent technical validation strengthens QTREX’s credibility with quantum-computing customers and supports its claim that the interconnect can address dense wiring needs. Finalizing a definitive partner agreement could convert this performance proof into a durable commercial position in quantum infrastructure.
Rapid Quantum Revenue ExpansionThe sharp H1 revenue increase demonstrates early commercial traction after the AME acquisition, while the reported gross margin indicates potential for attractive economics as activity scales. Converting validation work and initial orders into repeat deployments remains important to making this growth durable.
Defense-sector Commercial PathwayDeployment inside a major defense environment can provide a high-value reference customer and a pathway from customized development to broader commercial adoption. Exclusivity and phased commercialization may deepen QTREX’s role in demanding defense and quantum applications if milestones are completed.
Bears Say
Persistent Unprofitable OperationsMinimal revenue and negative gross profit show that the operating model has not yet achieved sustainable economics, despite recent growth from the acquired AME platform. Continued large losses could constrain reinvestment and make future performance dependent on successful commercial conversion.
Ongoing Cash BurnPersistent negative operating and free cash flow means current operations are consuming substantial cash rather than funding growth internally. If commercial deployments do not scale quickly, QTREX may need continued external financing to support quantum development and general operations.
Eroding Equity BaseModerate headline leverage does not remove the balance-sheet pressure created by recurring losses and shrinking equity. Continued erosion reduces financial resilience, limits flexibility during execution challenges, and can increase reliance on new capital to sustain the business.
QTREX Quantum Ltd News
QTEX FAQ
What was QTREX Quantum Ltd’s price range in the past 12 months?
QTREX Quantum Ltd lowest stock price was $0.28 and its highest was $3.85 in the past 12 months.
What is QTREX Quantum Ltd’s market cap?
QTREX Quantum Ltd’s market cap is $113.36M.
When is QTREX Quantum Ltd’s upcoming earnings report date?
QTREX Quantum Ltd’s upcoming earnings report date is Apr 01, 2027 which is in 172 days.
How were QTREX Quantum Ltd’s earnings last quarter?
QTREX Quantum Ltd released its earnings results on Aug 06, 2026. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.03 by -$0.11.
Is QTREX Quantum Ltd overvalued?
According to Wall Street analysts QTREX Quantum Ltd’s price is currently Overvalued.
Does QTREX Quantum Ltd pay dividends?
QTREX Quantum Ltd does not currently pay dividends.
What is QTREX Quantum Ltd’s EPS estimate?
QTREX Quantum Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QTREX Quantum Ltd have?
QTREX Quantum Ltd has 67,075,040 shares outstanding.
What happened to QTREX Quantum Ltd’s price movement after its last earnings report?
QTREX Quantum Ltd reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.03. Following the earnings report the stock price went down -1.852%.
Which hedge fund is a major shareholder of QTREX Quantum Ltd?
Currently, no hedge funds are holding shares in QTEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
QTREX Quantum Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Positive
Last 7 Days ▲ 12.4%
Last 30 Days ▲ 10.4%
Last 30 Days ▲ 10.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.12%
12-Months-Change
Fundamentals
Return on Equity
-278.14%
Trailing 12-Months
Asset Growth
356.22%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
QTREX Quantum Ltd
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
Technical Analysis
Ownership Overview
11.58% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
88.19% Public Companies and
Individual Investors